Melanoma in middle-aged and older men: A multi-institutional survey study of factors related to tumor thickness

Archives of Dermatology

Volumn 145, Issue 4, 2009, Pages 397-404

  Swetter, Susan M ^a,b   Johnson, Timothy M ^c   Miller, Donald R ^d,e,f   Layton, Christie J ^b   Brooks, Katie R ^e   Getter, Alan C ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; AWARENESS; CANCER DIAGNOSIS; CANCER LOCALIZATION; CONTROLLED STUDY; DOCTOR PATIENT RELATION; EDUCATION; GROUPS BY AGE; HEALTH CARE ACCESS; HEALTH SURVEY; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL CARE; MELANOMA; PRIORITY JOURNAL; SKIN CANCER; SKIN EXAMINATION; SOCIAL CARE;

AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; EDUCATIONAL STATUS; HEALTH EDUCATION; HUMANS; INSURANCE, HEALTH; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS;

EID: 65349128764     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.603     Document Type: Article

References (46)

1. Geller AC, Miller DR, Annas GD, Demierre MF, Gilchrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969-1999. JAMA. 2002;288(14): 1719-1720.
2. Ries LAG, Eisner MP, Kosary CL, et al. Surveillance Epidemiology and End Results cancer statistics review, 1975-2002. http://seer.cancer.gov/csr/1975- 2002/. Accessed May 1, 2008.
3. Giblin AV, Thomas JM. Incidence, mortality and survival in cutaneous melanoma. J Plast Reconstr Aesthet Surg. 2007;60(1):32-40.
4. National Center for Health Statistics. Vital Statistics Mortality Data Multiple Cause of Death Detail [machine-readable public use data tape]. Hyattsville, MD: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 1997.
5. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001; 19(16):3635-3648.
6. Balch CM, Soong SJ,Gershenwald JE, et al. Prognostic factors analysis of 17 600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001 ;19(16):3622-3634.
7. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001; 93(9):678-683.
8. Miller DR, Geller AC, Wyatt SW, et al. Melanoma awareness and selfexamination practices: results of a United States survey. J Am Acad Dermatol. 1996;34(6):962-970.
9. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma? patterns from a population-based survey. J Am Acad Dermatol. 1992; 26(6):914-919.
10. Swetter SM, Jung S, Harvell JD, Egbert BM. Increased proportion of lentigo maligna and lentigo maligna melanoma subtypes in the Veterans Affairs Palo Alto Health Care System and Stanford University Medical Center [abstract 228]. J lnvest Dermatol. 2002;119(1):245.
11. Rampen FHJ, Rumke P, Hart AAM. Patients' and doctors' delay in the diagnosis and treatment of cutaneous melanoma. Eur J Surg Oncol. 1989;15(2) 143-148.
12. Krige JE, Isaacs S, Hudson DA, King HS, Strover RM, Johnson CA. Delay in the diagnosis of cutaneous malignant melanoma: a prospective study in 250 patients. Cancer. 1991;68(9):2064-2068.
13. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA. 1999;281(7):640-643.
14. Richard MA, Grab JJ, Avril MF, et al. Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol. 1999;135(3):269-274.
15. Brady MS, Oliveria SA, Christos PJ, et al. Patterns of detection in patients with cutaneous melanoma. Cancer. 2000;89(2):342-347.
16. Richard MA, Grab JJ, Avril MR, et al. Delays in diagnosis and melanoma prognosis, II: the role of doctors. Int J Cancer. 2000;89(3):280-285.
17. Schwartz JL, Wang TS, Hamilton TA, Lowe L, SondakVK, Johnson TM. Thin primary cutaneous melanoma: associated detection patterns, lesion characteristics, and patient characteristics. Cancer. 2002;95(7):1562-1568.
18. Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol. 2005; 53(3):393-406.
19. Carli P, DeGiorgi VD, Palli D, et al; Italian Multidisciplinary Group on Melanoma. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol. 2003;139(5):607-612.
20. McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF. Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol. 2006;54(5):783-792.
21. Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol. 2007;143(4):488-494.
22. Resneck J Jr, Kimball AB. The dermatology workforce shortage. J Am Acad Dermatol. 2004;50(1):50-54.
23. Moore MM, Geller AC, Zhang Z, et al. Skin cancer examination teaching in US medical education. Arch Dermatol. 2006;142(4):439-444.
24. Ringborg U, Afzelius LE, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck: analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer. 1993; 71(3)751-758.
25. Cox NH, Aitchison TC, Sirel JM, MacKie RM; Scottish Melanoma Group. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer. 1996;73(7):940-944.
26. Koh HK, Michalik E, Sober AJ, et al. Lentigo maligna melanoma has no better prognosis than other types of melanoma. J Clin Oncol. 1984;2(9):994-1001.
27. Hanrahan PF, Hersey P, D'Este CA. Factors involved in presentation of older people with thick melanoma. Med J Aust. 1998;169(8):410-414.
28. BergenmarM, Ringbord U, MSnsson Brahme E, Brandberg Y. Nodular histogenetic type: the most significant factor for thick melanoma: implications for prevention. Melanoma Res. 1998;8(5):403-411.
29. Chamberlain AJ, Fritschi L, Giles GG, Dowling JP, Kelly JW. Nodular type and older age as the most significant associations of thick melanoma in Victoria, Australia. Arch Dermatol. 2002;138(5):609-614.
30. Crocetti E, Carli P. Changes from mid-1980s to late 1990s among clinical and demographic correlates of melanoma thickness. Eur J Dermatol. 2003;13(1): 72-75.
31. Demierre MF, Chung C, Miller DR, Geller AC. Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol. 2005; 141(6):745-750.
32. Carli P, De Giorgi V, Palli D, et al. Patterns of detection of superficial spreading and nodular-type melanoma: a multicenter Italian study. Dermatol Surg. 2004; 30(11):1371-1376.
33. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985;35(3):130-135.
34. Chamberlain AJ, Fritschi L, Kelly JW. Nodular melanoma: patients' perceptions of presenting features and implications for earlier detection. J Am Acad Dermatol. 2003;48(5):694-701.
35. Abbasi NR, Shaw HM, Rigel DS, et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292(22):2771-2776.
36. Kelly JW. Nodular melanoma: how current approaches to early detection are failing. J Drugs Dermatol. 2005;4(6):790-793.
37. University of Michigan Comprehensive Cancer Center. Skin cancer selfscreening card. http://www.cancer.med.umich.edu/prevention/self-screening- card.shtml. Accessed October 5, 2007.
38. Grab JJ, Bonerandi JJ. The "ugly duckling" sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134(1) :103-104.
39. BaumertJ, Plewig G, VolkenandtM, Schmid-WendtnerMH. Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol. 2007; 156(5):938-944.
40. Blum A, Brand CU, Ellwanger U, et al. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment. BrJ Dermatol. 1999;141(5):783-787.
41. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res. 2002; 12(4):389-394.
42. Sabel MS, StrecherVJ, Schwartz JL, et al. Patterns of Internet use and impact on patients with melanoma. J Am Acad Dermatol. 2005;52(5):779-785.
43. Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC. Patient adherence to skin self-examination: effect of nurse intervention with photographs. Am J Prey Med. 2004;26(2):152-155.
44. Norman SA, Localio AR, Zhou L, et al. Validation of self-reported screening mammography histories among women with and without breast cancer. Am J Epidemiol. 2003;158(3):264-271.
45. Lasithiotakis K, Leiter U, Meier F, et al. Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer. 2008; 112(8)1795-1894.
46. Geller AC, Johnson TM, Miller DR, Brooks KR, Layton CJ, Swetter SM. Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol. 2009;145(4):409-414.